Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2014-11-14, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: SKBI/20141114/10-Q/1/000.htm SEC Original: v393723_10q.htm

---

---

Webplus: SKBI/20141114/10-Q/2_EX-10.2/000.htm SEC Original: v393723_ex10-2.htm
EMPLOYMENT AGREEMENT Agreement Executive Company This EMPLOYMENT AGREEMENT (this “ WHEREAS, the Company desires to employ Executive as its Chief Financial Officer on the terms and conditions as set forth hereinafter, and Executive desires to be so employed; NOW, THEREFORE, IN CONSIDERATION of the foregoing facts, the mutual covenants and agreements contained herein and other good and valuable consideration, the

---

---

Webplus: SKBI/20141114/10-Q/3_EX-31.1/000.htm SEC Original: v393723_ex31-1.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20141114/10-Q/4_EX-31.2/000.htm SEC Original: v393723_ex31-2.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20141114/10-Q/5_EX-32.1/000.htm SEC Original: v393723_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2014 Weibing Lu Chief Executive Officer

---

---

Webplus: SKBI/20141114/10-Q/6_EX-32.2/000.htm SEC Original: v393723_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2014 Bing Mei Chief Financial Officer

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2014-11-14, XBRL Interactive FinancialsCIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4
XIAN PROVINCE